Ultragenyx Pharmaceutical(MX:RARE)
MX$256.000.00 (0.00%)
MX:RARE
Ultragenyx Pharmaceutical earnings date
MX$256.00
At close:0.00 (0.00%)
Ultragenyx Pharmaceutical (RARE) Q2 2023 Earnings Report
1 Followers
MX:RARE Q2 2023 EPS Results
- Actual EPS
- -MXN 41.91
- Consensus EPS
- -MXN 38.93
- Beat/Miss
- Missed by -MXN 2.98
- One Year Ago EPS
- -MXN 42.09
MX:RARE Q2 2023 Revenue Results
- Actual Revenue
- MXN 2.02B
- Expected Revenue
- MXN 1.95B
- Beat/Miss
- Beat by +MXN 65.26M
- YoY Revenue Growth
- +21.23%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/03/2023
- Time
- After Close
- Conference Call
- Thursday, August 3, 2023
MX:RARE Upcoming Earnings
Ultragenyx Pharmaceutical's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
MX:RARE Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:RARE Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | 40.81- | -24.03 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | -20.49-21.61 | -33.71 | 35.91% (+12.11) | |
| Aug 04, 2026 | 2026 (Q2) | -23.13-16.76 | -21.79 | 23.08% (+5.03) | |
| May 05, 2026 | 2026 (Q1) | -27.71-34.27 | -29.24 | -17.20% (-5.03) | |
| Feb 12, 2026 | 2025 (Q4) | -20.36-24.03 | -25.89 | 7.19% (+1.86) | |
| Nov 04, 2025 | 2025 (Q3) | -22.98-33.71 | -26.08 | -29.29% (-7.64) | |
| Aug 05, 2025 | 2025 (Q2) | -24.16-21.79 | -28.31 | 23.03% (+6.52) | |
| May 06, 2025 | 2025 (Q1) | -29.76-29.24 | -37.81 | 22.66% (+8.57) | |
| Feb 13, 2025 | 2024 (Q4) | -24.36-25.89 | -28.31 | 8.55% (+2.42) | |
| Nov 05, 2024 | 2024 (Q3) | -27.64-26.08 | -41.53 | 37.22% (+15.46) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
